



Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright 
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
 Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
 You may not further distribute the material or use it for any profit-making activity or commercial gain 
 You may freely distribute the URL identifying the publication in the public portal 
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
  
 
   
 
 
Downloaded from orbit.dtu.dk on: May 03, 2019
Levels of Systemic Low-grade Inflammation in Pregnant Mothers and Their Offspring
are Correlated
Fink, Nadia Rahman; Chawes, Bo; Bønnelykke, Klaus; Thorsen, Jonathan; Stokholm, Jakob;
Rasmussen, Morten Arendt; Brix, Susanne; Bisgaard, Hans
Published in:
Scientific Reports





Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Fink, N. R., Chawes, B., Bønnelykke, K., Thorsen, J., Stokholm, J., Rasmussen, M. A., ... Bisgaard, H. (2019).
Levels of Systemic Low-grade Inflammation in Pregnant Mothers and Their Offspring are Correlated. Scientific
Reports, 9(1), [3043]. https://doi.org/10.1038/s41598-019-39620-5
1Scientific RepoRts |          (2019) 9:3043  | https://doi.org/10.1038/s41598-019-39620-5
www.nature.com/scientificreports
Levels of systemic Low-grade 
Inflammation in Pregnant Mothers 
and Their Offspring are Correlated
Nadia Rahman Fink1, Bo Chawes  1, Klaus Bønnelykke  1, Jonathan Thorsen  1, 
Jakob Stokholm  1,2, Morten Arendt Rasmussen1,3, susanne Brix  4 & Hans Bisgaard  1
High sensitivity C-reactive protein (hs-CRP) is a marker of systemic low-grade inflammation and 
associated with chronic inflammatory diseases. It is unknown whether maternal and infant hs-CRP levels 
are correlated and little is known about risk factors in early childhood. Hs-CRP were measured in mothers 
during pregnancy week 24 (N = 690), and one-week postpartum (N = 675) and in their children age 6 
mo (N = 640) enrolled in the Copenhagen Prospective Studies on Asthma in Childhood2010 (COPSAC2010) 
cohort. The risk factor analysis included anthropometrics, environmental exposures and CRP-Genetic 
Risk Score (GRS). Mother’s body mass index (BMI), use of antibiotics, smoking, cesarean delivery and 
season were associated with higher maternal hs-CRP level, whereas higher social circumstances were 
associated with lower hs-CRP level (p < 0.05). Child’s BMI, siblings, bacterial airway colonization, 
current infection, CRP-genetic risk score and season were associated with higher hs-CRP at age 6 mo (all 
p < 0.05). Mother’s hs-CRP level in pregnancy week 24 was associated with hs-CRP level in the child at 6 
mo: β-coefficient = 0.11 [95% CI: 0.01–0.20], R2 = 0.22, p = 0.03. The association was unchanged adjusted 
for all significant risk factors. Systemic low-grade inflammation in pregnant mothers and their offspring 
is correlated independently of BMI, environmental exposures and genetic risk factors.
C-reactive protein (CRP) level has been reported to be elevated in pregnant women without pregnancy complica-
tions as compared to non-pregnant women1,2. The degree of this low-grade systemic inflammation in pregnancy 
has been associated with environmental exposures including smoking and diet3,4, and with conditions such as 
preeclampsia, obesity and gestational diabetes, which are all well-known fetal stressors that can cause devel-
opmental adaptions5–8. Chronic low-grade inflammation in pregnancy is suspected to be potentially harmful 
for the developing fetus9, and may initiate a trajectory towards immune diseases such as asthma and allergy in 
childhood10.
There is a paucity of studies investigating risk factors for systemic low-grade inflammation in early life, but we 
and other groups have previously linked hs-CRP levels to neonatal lung function11, allergic sensitization12, and 
childhood obesity4, which may in turn affect the child’s risk of developing other chronic inflammatory disorders 
later in life13.
We hypothesized that systemic low-grade inflammation in pregnant women may influence the child’s risk 
of such inflammation. To investigate this link, we examined the association between levels of hs-CRP meas-
ured in mother-child pairs participating in the Copenhagen Prospective Studies on Asthma in Childhood2010 
(COPSAC2010) cohort adjusting for anthropometrics, genetics and environmental confounders.
Methods
Study population. The participants were from the ongoing clinical COPSAC2010 population-based moth-
er-child cohort14. A total of 738 pregnant women were recruited for the COPSAC2010 cohort, whereof 38 withdrew 
before giving birth. There were five twin pairs in the cohort; only one child of each twin-pair was used in the 
analysis to avoid duplicating mothers’ data, leaving 695 mother-child pairs in this study. Further detail on recruit-
ment, inclusion and exclusion criteria were previously described in detail15.
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Ethics. The study was conducted in accordance with the guiding principles of the Declaration of Helsinki 
and was approved by the National Committee on Health Research Ethics (H-B-2008-093) and the Danish Data 
Protection Agency (2015-41-3696). Both parents gave oral and written informed consent before enrolment.
Assessment of hs-CRP levels. Blood was drawn from a cubital vein into an EDTA tube from women at 
pregnancy week 24 and one-week postpartum and from children at age 6 months, centrifuged to separate plasma 
and cells, and immediately stored at −80 °C until analysis. After thawing of samples, hs-CRP levels were deter-
mined by a high sensitivity electrochemiluminescence-based assay from MesoScale Discovery. Samples were 
measured in duplicate and read by using the Sector Image 2400 A (Meso Scale Discovery, Gaitherburg, MD). The 
lower limit of detection of CRP was 0.007 ng/mL.
Risk factors. All data were retrieved and entered in a dedicated online database at clinical interviews with the 
parents at the COPSAC research unit using predefined questions with closed response categories. The families 
visited the research unit at week 24 and 36 of pregnancy, one-week postpartum and subsequently at child age 1 
week, 1, 3 and 6 months.
We collected information regarding mothers’ doctor-diagnosed asthma, allergy or eczema (yes/no), smoking 
during pregnancy (yes/no), antibiotic use during pregnancy prior to mothers’ blood sampling (yes/no), par-
ity/prior birth (yes/no) and preeclampsia (yes/no). Mothers’ body mass index (BMI) was calculated based on 
pre-pregnancy weight and height collected from the participant pregnancy charts and matched with data from 
the Danish Fetal Database. Data on pre-pregnancy BMI, parity, preeclampsia and antibiotic use in pregnancy 
were validated against national register data.
Socioeconomic status was represented as the z-score of principle component 1 from a principle component 
analysis including household income, mothers’ age and level of education.
The child’s length and weight were measured at the COPSAC clinic at age 6 months. Age- and gender specific 
BMI z-scores were subsequently calculated using WHO standardized macros. Exclusive breastfeeding for more 
than 4 months (yes/no), daycare start before age 6 months (yes/no), siblings at home (yes/no), cat (yes/no) and 
dog (yes/no) in the home were registered. Bacterial colonization of the airway with M. catharralis, H. influenzae 
and/or S. pneumoniae (yes/no) at age 4 weeks was determined as previously detailed16.
Current infection in a period of two weeks prior to the children’s blood sampling was determined by diary 
reported symptoms for more than one day of upper or lower respiratory tract infections, ear or throat pain, gas-
troenteritis or fever with unknown cause (yes/no).
The child’s CRP-genetic risk score (GRS) was calculated based on 17 single nucleotide polymorphisms (SNPs), 
selected based on a meta-analysis of genome-wide association studies (GWAS)17. The final score was based on the 
sum of risk alleles weighted on their reported effect size on CRP levels17 and subsequently z-score transformed.
Season of blood sampling was analyzed based on the day in year of sampling, day 1 to 365. Due to sinusoid dis-
tribution of data, it was transformed using a function taking such distribution into account (see Supplementary 
Methods for details).
Statistical analysis. Levels of hs-CRP were log-transformed prior to analysis. Before log-transformation, 
the lower limit of detection was added to all completed measurements as a pseudo-count to avoid zero values.
Baseline characteristics of included and excluded children were analyzed by chi square test for categorical 
variables and by t-test for continuous variables. We analyzed risk factor associations with level of hs-CRP at each 
time-point separately (mothers’ level at pregnancy week 24, one-week postpartum, and child age 6 months) by 
using univariate linear models. Thereafter, we analyzed the associations between levels of hs-CRP at the three 
time-points using multivariable linear regression models adjusting for all significant risk factors (p < 0.05). 
Goodness of model fit was evaluated by marginal R squared values.
Finally, we conducted an analysis of the associations between levels of hs-CRP at the three time-points using 
a multivariable linear regression model with all risk factors included using a backward selection procedure elimi-
nating risk factors stepwise until only significant risk factors (p < 0.05) were retained in the model.
All statistical analysis were done using the statistical software program ‘R’ version 3.2.3 (The R Foundation for 
Statistical Computing) and visualized with the “ggplot2” package.
Governance. We are aware of and comply with recognized codes of good research practice, including 
the Danish Code of Conduct for Research Integrity. We comply with national and international rules on the 
safety and rights of patients and healthy subjects, including Good Clinical Practice (GCP) as defined in the EU’s 
Directive on Good Clinical Practice, the International Conference on Harmonisation’s (ICH) good clinical prac-
tice guidelines and the Helsinki Declaration. We follow national and international rules on the processing of 
personal data, including the Danish Act on Processing of Personal Data and the practice of the Danish Data 
Inspectorate.
Results
Baseline characteristics. Blood samples were collected from 690 (99%) of the mothers at pregnancy week 
24 and from 675 (97%) at one-week postpartum. At age 6 months, blood was collected from 640 (92%) of the 
children. A total of 622 (90%) mother-child pairs had blood available from all three time-points (Fig. 1). Baseline 
characteristics for included and excluded participants (with samples at all three time points) are represented in 
Table 1, showing no significant differences.
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Risk factors of CRP levels in mother and child. Pregnancy week 24 included 690 samples, with hs-CRP 
Geometric Mean (GM) value = 5.70 mg/L and none below detection limit. Antibiotic use before pregnancy week 
24, was associated with higher level of hs-CRP: GM, 6.75 vs. 5.41 mg/L; geometric mean ratio (GMR), 1.25 [95% 
Confidence Interval (CI): 1.03–1.50], p = 0.02. Women who smoked during pregnancy had higher hs-CRP: 
GM, 8.05 vs. 5.54 mg/L; GMR, 1.45 [95% CI: 1.07–1.97], p = 0.02, which was also the case for women with a 
pre-pregnancy BMI above 25 kg/m2: GM, 8.28 vs. 4.64 mg/L; GMR, 1.09 [95% CI: 1.07–1.11], p < 0.01. Social cir-
cumstances, z-score above 0, was negatively associated with hs-CRP: GM, 5.26 vs. 6.16 mg/L; GMR, 0.90 [95% CI: 
0.83–0.98], p = 0.02, i.e. related to mothers education (higher), age (higher) and income level (higher). Moreover, 
season of sampling was significantly associated with the level of hs-CRP (p < 0.01), with higher levels of hs-CRP 
in winter compared to summer.
Mothers’ asthma, allergy or eczema, cat or dog in the household, preeclampsia and number of previous full 
born pregnancies (parity) were not associated with hs-CRP levels (Table 2 and Supplement Fig. 1a).
One-week postpartum included 675 samples, with hs-CRP GM = 16.91 mg/L, and none below detection limit. 
One week postpartum levels were up to 3-fold higher than at week 24 of pregnancy. Delivery mode was associ-
ated with higher hs-CRP: cesarean section vs. vaginal delivery, GM, 21.17 vs. 15.93 mg/L; GMR 1.33 [95% CI: 
1.04–1.70], p = 0.02, likewise for pre-pregnancy BMI above 25 kg/m2: GM, 19.90 vs 15.65 mg/L; GMR, 1.03 [95% 
CI: 1.00–1.05], p = 0.02, and season of sampling, with higher levels in summer compared to winter, p < 0.01.
Antibiotic use during pregnancy, mothers with asthma, allergy or eczema, cat or dog in the household, preec-
lampsia, parity and social circumstances were not associated with the level of hs-CRP (Table 2 and Supplement 
Fig. 1b).
Child age 6 months included 640 samples, with GM = 0.14 mg/L, and none below detection limit. Living 
with at least one older sibling was significantly associated with higher hs-CRP: GM, 0.18 vs. 0.10 mg/L; GMR, 
1.85 [95% CI: 1.55–2.22], p < 0.01, similarly for neonatal bacterial airway colonization at week 4: GM, 0.18 vs. 
0.12 mg/L; GMR, 1.53 [95% CI: 1.24–1.87], p < 0.01, BMI z-score above 0: GM, 0.15 vs. 0.13 mg/L; GMR, 1.11 per 
BMI point [95% CI: 1.00–1.23], p = 0.04, and season of sampling, with higher levels in winter compared to sum-
mer, p < 0.01. A CRP-Genetic risk score (z-score) above 0 was also associated with higher hs-CRP: GM, 0.17 vs. 
0.11 mg/L; GMR, 1.27, [95%CI: 1.15–1.40], p < 0.01, and likewise for having an infection 14 days prior to blood 
sampling: GM, 0.22 vs. 0.11 mg/L; GMR, 2.08 [95% CI: 1.70–2.54], p < 0.01.
Mothers with asthma, allergy or eczema, living with cat or dog, daycare start before age 6 months, exposure 
to passive smoking, delivery by cesarean section, male sex, exclusive breastfeeding for more than 4 months and 
social circumstances were not associated with the hs-CRP at 6 months (Table 2 and Supplement Fig. 1c).
Association between hs-CRP levels during pregnancy and from mother to child. To examine the 




N = 73* p-value
Current Infection, N (%) 170 (27.3) 5 (18.5) 0.21
Mother BMI, mean (Standard Deviation (SD)) 24.56 (4.47) 24.49 (3.75) 0.91
Preeclampsia, N (%) 25 (4.0) 7 (9.6) 0.06
Antibiotic use in pregnancy, N (%) 229 (36.9) 24 (32.9) 0.59
Cesarean section (Delivery), N (%) 129 (20.7) 21 (28.8) 0.15
Male sex, N (%) 315 (51.1) 34 (49.3) 0.88
Child BMI, mean z-score (SD) 0.06 (0.91) 0.22 (1.05) 0.15
Parity, prior birth > 0, N (%) 339 (54.5) 37 (50.7) 0.62
Social circumstances, mean z-score (SD) −0.00 (1.00) −0.02 (1.01) 0.91
Smoking in pregnancy, N (%) 44 (7.1) 10 (13.7) 0.08
Cat in household in pregnancy, N (%) 129 (20.7) 16 (21.9) 0.94
Dog in household in pregnancy, N (%) 122 (19.6) 19 (26.0) 0.26
Cat in household in the 1st year, N (%) 137 (22.3) 14 (20.6) 0.87
Dog in household in the 1st year, N (%) 131 (21.3) 19 (27.9) 0.27
Fathers with asthma, allergy or eczema, N (%) 263 (43.5) 29 (40.8) 0.77
Mothers with asthma, allergy or eczema, N (%) 330 (53.1) 43 (58.9) 0.42
Neonatal bacterial airway colonization, N (%) 177 (29.4) 15 (23.1) 0.36
CRP-genetic risk score, mean z-score (SD) 0.01 (0.99) −0.14 (1.09) 0.33
Passive smoking, N (%) 88 (14.3) 13 (19.1) 0.38
Daycare start before 6 months, N (%) 23 (3.7) 3 (4.4) 1.00
Solely breastfed for more than 4 months, N (%) 0.54 (0.50) 0.50 (0.50) 0.54
Older siblings at home, N (%) 357 (57.4) 37 (50.7) 0.33
Table 1. Baseline characteristics of the study population. *Population including all CRP measurements from 
mothers’ week 24, week-one postpartum and children age 6 months. Note, that due to missing data for the 
distinct exposure variable, sample size may vary.
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and child, we performed a multivariable analysis adjusting for all significant risk factors (p < 0.05) from both of 
the two time points being compared (Table 2).
The comparisons revealed significant associations between hs-CRP levels at all three time-points: mother 
week 24 of pregnancy vs. mother one-week postpartum, adjusted for social circumstances, season, BMI, delivery 
mode, antibiotics and smoking: β-coefficient = 0.39 [95% CI: 0.29–0.48], p < 0.01, R2 = 0.12; mother week 24 of 
pregnancy vs. child age 6 months, adjusted for infections, siblings, airway bacteria, social circumstances, sea-
son, CRP-GRS, antibiotics, smoking, child and mother BMI: β-coefficient = 0.11 [95% CI: 0.01–0.20], p = 0.03, 
Yes (N), GM, 
mg/L
No (N), GM, 
mg/L GMR 95% CI p-value
Pregnancy week 24 (N = 690)
Antibiotics during pregnancy (173) 6.75 (516) 5.41 1.25 [1.03–1.50] 0.02
Mothers with asthma, allergy or eczema (368) 5.53 (321) 5.92 0.93 [0.79–1.10] 0.43
Cat in household during pregnancy (143) 6.05 (547) 5.62 1.08 [0.88–1.32] 0.47
Dog in household during pregnancy (140) 6.04 (550) 5.62 1.08 [0.88–1.32] 0.50
Preeclampsia (31) 7.50 (659) 5.63 1.33 [0.90–1.98] 0.14
Smoking in pregnancy (54) 8.05 (636) 5.54 1.45 [1.07–1.97] 0.02
Mothers’ BMI, per BMI point* 1.09 [1.07–1.11] <0.01
Mothers’ BMI > 25 kg/m2** (245) 8.28 (440) 4.64
Parity, multipara (374) 5.68 (316) 5.73 0.99 [0.84–1.17] 0.92
Social-circumstances, per z-score point* 0.90 [0.83–0.98] 0.02
Social-circumstances, z-score > 0** (337) 5.26 (353) 6.16
Season of sampling — — — — <0.01
One-week postpartum (N = 675)
Antibiotics during pregnancy (248) 18.12 (426) 16.17 1.12 [0.91–1.38] 0.28
Mothers with asthma, allergy or eczema (360) 16.47 (314) 17.50 0.94 [0.77–1.15] 0.55
Cat in household during pregnancy (141) 17.67 (534) 16.73 1.06 [0.83–1.36] 0.66
Dog in household during pregnancy (135) 15.65 (540) 17.25 0.91 [0.71–1.17] 0.45
Preeclampsia (29) 17.70 (646) 16.88 1.05 [0.64–1.72] 0.85
Smoking in pregnancy (49) 18.61 (626) 16.79 1.11 [0.75–1.63] 0.60
Mother’s BMI, per BMI point* 1.03 [1.00–1.05] 0.02
Mother’s BMI > 25 kg/m2** (236) 19.90 (435) 15.65
Parity, multipara (367) 17.12 (308) 16.68 1.03 [0.84–1.26] 0.78
Cesarean section (143) 21.17 (532) 15.93 1.33 [1.04–1.70] 0.02
Social-circumstances, per z-score point* 0.93 [0.84–1.03] 0.16
Social-circumstances z-score > 0** (331) 15.77 (344) 18.10
Season of sampling — — — — <0.01
Child age 6 months (N = 640)
Neonatal bacterial airway colonization (182) 0.18 (436) 0.12 1.53 [1.24–1.87] <0.01
Older siblings at home (365) 0.18 (275) 0.10 1.85 [1.55–2.22] <0.01
Mothers with asthma, allergy or eczema (342) 0.13 (297) 0.15 0.88 [0.73–1.06] 0.16
Cat in household in the 1st year (141) 0.12 (492) 0.14 0.83 [0.67–1.04] 0.11
Dog in household in the 1st year (137) 0.13 (496) 0.14 0.95 [0.75–1.19] 0.57
Current infection (173) 0.22 (375) 0.11 2.08 [1.70–2.54] <0.01
Daycare start before age 6 months (24) 0.15 (610) 0.14 1.11 [0.68–1.81] 0.67
Passive smoking (90) 0.12 (543) 0.14 0.86 [0.66–1.12] 0.32
Cesarean section (137) 0.12 (503) 0.14 0.84 [0.68–1.07] 0.16
Sex, male (326) 0.13 (309) 0.14 0.89 [0.74–1.07] 0.23
Solely breastfed > 4 months (346) 0.15 (292) 0.12 1.18 [0.98–1.43] 0.08
BMI at 6 months, per z-score point* 1.11 [1.00–1.23] 0.04
BMI at 6 months, z-score > 0** (319) 0.15 (316) 0.13
CRP-genetic risk score, per z-score point* 1.27 [1.15–1.40] <0.01
CRP-genetic risk score, z-score > 0** (304) 0.17 (278) 0.11
Social circumstances, per z-score point* 1.03 [0.93–1.12] 0.49
Social circumstances, z-score > 0** (309) 0.15 (331) 0.13
Season of sampling — — — — <0.01
Table 2. Risk factor analysis of CRP levels at pregnancy week 24 (N = 690), one-week postpartum (N = 675) 
and children age 6 months (N = 640). GM = geometric mean, GMR = geometric mean ratio. *GMR based on 
continuous variable. Per z-score point. **Dichotomized variable to evaluate GM(mg/L) in two groups.
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R2 = 0.22; and mother one-week postpartum vs. child age 6 months, adjusted for infections, siblings, airway 
bacteria, season, delivery, CRP-GRS, child and mother BMI: β-coefficient = 0.09 [95% CI: 0.01–0.16], p = 0.03, 
R2 = 0.23), respectively (Fig. 2, Table 3).
The above multivariable models including all significant risk factors from the univariate analyses compared 
to multivariable models including all risk factors with a backward selection procedure showed similar effect 
estimates and R2 values. Backward selection models of mother week 24 of pregnancy vs. one-week postpartum: 
β-coefficient = 0.37 [95% CI: 0.27–0.45], p < 0.01, R2 = 0.10; mother week 24 of pregnancy vs. child age 6 months: 
β-coefficient = 0.11 [95% CI: 0.02–0.21], p = 0.02, R2 = 0.21, and mother one-week postpartum vs. child age 6 
months: β-coefficient = 0.08 [95% CI: 0.01–0.16], p = 0.047, R2 = 0.22 (Table 3).
Supplementary multivariable analyses were done on the associations between mother and child hs-CRP strat-
ified for current infection, i.e. with and without current infections, showing a similar positive association in both 
strata (Supplementary Table 1). The correlation coefficients were largely the same in both strata suggesting that 
the covariates we adjusted the models for play a larger role for the size of the correlation coefficient than the 
higher hs-CRP levels in children with a history of infection.
Finally, to exclude that pleiotropic gene effects for hs-CRP and BMI could influence the findings we ana-
lyzed the association between child hs-CRP, the CRP-GRS and BMI. Increasing hs-CRP levels were associated 
with increasing CRP-GRS z-score: β-coefficient = 0.24 [95% CI: 0.14–0.34], p < 0.01, and with increasing BMI 
z-score: β-coefficient = 0.11 [95% CI: 0.01–0.21], p < 0.01. However, the CRP-GRS was not associated with BMI: 
β-coefficient = 0.03 [95% CI: −0.04–0.11], p = 0.35.
Discussion
Primary findings. Systemic low-grade inflammation assessed by hs-CRP levels were correlated during preg-
nancy and from pregnant women to their child. Higher hs-CRP levels during pregnancy and in early childhood 
were associated with higher mother and child BMI, cesarean section, smoking, infections, older siblings, bac-
terial airway colonization, a higher CRP genetic risk score, lower social circumstances and season of sampling. 
The associations between hs-CRP levels in the mother-child pairs were robust for adjustment for these risk fac-
tors, suggesting that intrauterine programming or additional unmeasured host, genetic or environmental factors 
might drive these mother-to-child hs-CRP correlations.
Strengths and limitations. Previous studies have investigated risk factors of elevated hs-CRP in preg-
nant women2 and in children of varying ages18, but this is the first study providing a large dataset of pairwise 
Figure 1. Flowchart of included mothers and children.
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assessments of hs-CRP in mothers and their children investigating whether low-grade systemic inflammation 
during pregnancy and early childhood are correlated.
The detailed, longitudinally collected information on anthropometrics, pregnancy complications, birth, and 
early childhood exposures is a significant strength of the study providing the foundation for robust confounder 
adjustments. All data were collected at the COPSAC research clinic following predefined standard operating 
procedures and doctor interviews based on questions with closed response categories, which ensure high quality 
assessments. Furthermore, whenever possible, data were validated against national register databases.
The detailed information on symptoms of infections captured by daily diary registrations and validated at 
visits to the COPSAC clinic15 is another significant advantage of the study as CRP is known to be elevated during 
and after infections19.
We calculated a CRP-genetic risk score based on the only available CRP meta-GWAS, which predominantly 
included data from adults17. This GRS appeared to be sensitive also in children as it was strongly associated with 
hs-CRP levels at age 6 months. However, the CRP-genetic risk score only explained part of the total variance of 
the hs-CRP levels; consequently, we cannot rule out that other genes may influence the CRP levels and the cor-
relation between mother and child levels. Interestingly, the association between hs-CRP levels in mothers and 
their children persisted after adjusting for the genetic risk score, which argues against this association being solely 
genetically determined. Still, other genes may explain the observed correlation, particularly pleiotropic gene 
effects, e.g. shared risk variants for hs-CRP and BMI/overweight, which have shown to be coupled20. However, 
the CRP-genetic risk score was not associated with BMI in our data, which argues against a pleitropic gene effect.
Figure 2. Correlation of systemic low-grade inflammation between mother and child, from pregnancy week 24, 
1 week postpartum and child age 6 months.
Est. 95% CI R2 p-value
Mother pregnancy week 24 vs. one-week postpartum
Crude analysis 0.37 [0.29–0.46] 0.09 <0.01
Multivariable analysis with all significant risk factors (p < 0.05) 0.39 [0.29–0.48] 0.12 <0.01
Multivariable analysis with backward selection 0.37 [0.27–0.45] 0.10 <0.01
Mother pregnancy week 24 vs. child age 6 months
Crude analysis 0.10 [−0.01–0.16] 0.01 0.07
Multivariable analysis with all significant risk factors (p < 0.05) 0.11 [0.01–0.20] 0.22 0.03
Multivariable analysis with backward selection 0.11 [0.02–0.21] 0.21 0.02
Mother one-week postpartum vs. child age 6 months
Crude analysis 0.08 [0.01–0.15] 0.01 0.03
Multivariable analysis with all significant risk factors (p < 0.05) 0.09 [0.01–0.16] 0.23 0.03
Multivariable analysis with backward selection 0.08 [0.01–0.16] 0.22 0.047
Table 3. Multivariable association analysis of CRP levels with adjustment for all risk factors with p < 0.05, and 
multivariable association analysis of CRP with backward selection procedure.
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The final multivariable regression models accounting for all potential confounders in our dataset revealed a 
consistent association between hs-CRP levels in mother and child with a marginal R2 up to 25%, which illustrates 
a good model fit, but also underscores that 75% of the variation remains unexplained.
Interpretation. We found that degree of low-grade systemic inflammation determined by levels of hs-CRP 
in pregnant mothers and their children at age 6 months were correlated. The immune status of a pregnant woman 
is altered, which is mirrored in elevated CRP levels even during normal pregnancies1,2. Animal studies have not 
revealed any evidence of transplacental transport of CRP molecules to the fetus21, while human studies are lack-
ing. The half-life of CRP is only 19 hours22. Therefore a direct transfer of CRP molecules is not a likely explanation 
for the observed correlation between maternal and child CRP levels.
There is however evidence that some immune cells, cytokines and chemokines may cross the placenta, with 
varying transplacental transfer in different stages of pregnancy, probably due to the fetus’ different needs during 
the different developmental phases23. The degree of inflammation and level of hs-CRP in the mother has been 
shown to regulate the flow of nutrients across placenta23, which may indirectly influence the immune status of 
the developing fetus, causing low-grade systemic inflammation. We observed correlation of hs-CRP levels from 
mother to child using both pregnancy week 24 and one-week postpartum assessments, which argues against a 
restriction of this phenomenon to specific pregnancy periods. Assessment of fathers hs-CRP level and investigat-
ing whether these were correlated with child levels would have provided important information on whether the 
observed association between mother and child levels were due to in utero programming of the fetus.
The validity of the hs-CRP assessments in the mothers is assured by reliable associations to several known 
risk factors such as maternal pre-pregnancy BMI above 25 kg/m223. Moreover, antibiotic usage reflects a history 
of infections, which has been shown to result in elevated CRP for several weeks after the infection19, inflamma-
tion due to wound healing is well-known following cesarean section22, and smoking is known to cause airway 
and systemic inflammation3. Low social circumstances may be associated with a life-style more often includ-
ing unhealthy dieting and proneness to develop inflammation24 and chronic inflammatory diseases25. Adjusting 
for these risk factors in the association analysis between hs-CRP at the maternal sampling points and between 
mother and child revealed even stronger associations and higher R2 values.
Even though the levels of hs-CRP increased dramatically from pregnancy week 24 to week 1 post partum, 
probably caused by giving birth, we still observed a specific hs-CRP signature of the individual mother, with 
e.g. maternal pre-pregnancy BMI as a common risk factor at both time points and a strong correlation between 
hs-CRP levels during pregnancy. The same was apparent for the correlation between mother and child hs-CRP 
levels even though the child’s hs-CRP levels were magnitudes lower. These observations point towards common 
effectors in mother and child.
We have previously demonstrated that neonatal bacterial airway colonization increases the risk of respiratory 
infections in early life26. Siblings in the household is moreover a well-known risk factor for infectious burden in 
the child27. We also found season to have a significant influence on the level of inflammation, which has also been 
observed in other studies28. We observed higher levels in mothers at pregnancy week 24 and child age 6 months 
during winter vs. summer, which may be due to an increased infectious load during winter, whereas the opposite 
was the case for hs-CRP levels at 1 week postpartum, which may be influenced by the recent childbirth. Finally, 
hs-CRP level was associated with the diary-verified history of current infections, which serves as a biological 
validation of the data.
Interestingly, we observed that higher BMI in both the mother and child was closely associated with higher 
level of hs-CRP. Overweight and obesity are known to be associated with systemic inflammation and hs-CRP lev-
els in both children, adolescents and adults20, but an association between BMI in healthy infants and hs-CRP level 
has not been described previously. A few studies have shown that obesity in pregnancy is linked to risk of obesity 
and low-grade systemic inflammation in their children5,6, proposing this as the mechanism responsible for our 
observation of hs-CRP correlation from mother to child. However, adjusting the analysis for BMI still showed 
a significant association, indicating that this inflammatory trait is not exclusively related to BMI and obesity29.
This study investigates a wide range of environmental variables and finds strong correlations between hs-CRP 
level in mothers and their offspring independently of these factors. Still, it is a possibility that other environmental 
factors could account for additional effects on the level of hs-CRP and explain the correlation between mother 
and child levels. Our study demonstrates correlation of low-grade systemic inflammation from pregnant mothers 
to their children already by age 6 months. It can be speculated that this will influence the child’s risk of developing 
overweight and chronic inflammatory disorders later in childhood, but such cause-effect cannot be determined 
by our data.
Conclusion
Systemic low-grade inflammation assessed by hs-CRP levels in pregnant mothers and their children are corre-
lated independent of anthropometrics, environmental exposures during pregnancy and early childhood and CRP 
genetics. We speculate that this is suggestive of in utero programming of the fetus, which could have long-term 
health consequences for the child.
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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